Arkolith/Insider Trading/PTHS/Form 4

Ligand Pharmaceuticals Inc

10% OwnerPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed Jul 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2025Conversion(C)1.5M$10.00$15.0M1.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2025Other(J)31K——34K
Jul 1, 2025Conversion(C)15K—$03K

Transaction Codes

C
Conversion of a derivative
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-093589) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML